These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18305140)

  • 1. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.
    Mallone R; Martinuzzi E; Blancou P; Novelli G; Afonso G; Dolz M; Bruno G; Chaillous L; Chatenoud L; Bach JM; van Endert P
    Diabetes; 2007 Mar; 56(3):613-21. PubMed ID: 17327428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
    Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
    Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
    Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
    Jarchum I; Baker JC; Yamada T; Takaki T; Marron MP; Serreze DV; DiLorenzo TP
    Diabetes; 2007 Oct; 56(10):2551-60. PubMed ID: 17620420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
    Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
    Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
    Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
    J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
    Sévère S; Gauvrit A; Vu AT; Bach JM
    Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
    Marée AF; Santamaria P; Edelstein-Keshet L
    Int Immunol; 2006 Jul; 18(7):1067-77. PubMed ID: 16728432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes.
    Kishi M; Yasuda H; Abe Y; Sasaki H; Shimizu M; Arai T; Okumachi Y; Moriyama H; Hara K; Yokono K; Nagata M
    Biochem Biophys Res Commun; 2010 Mar; 394(1):228-32. PubMed ID: 20206130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
    Han B; Serra P; Amrani A; Yamanouchi J; Marée AF; Edelstein-Keshet L; Santamaria P
    Nat Med; 2005 Jun; 11(6):645-52. PubMed ID: 15908957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.
    Rathmann S; Rajasalu T; Rosinger S; Schlosser M; Eiermann T; Boehm BO; Durinovic-Belló I
    Ann N Y Acad Sci; 2004 Dec; 1037():22-5. PubMed ID: 15699489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
    Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
    Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
    J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.